| #142 |
Sachin Pannuri |
Cambrex Karlskoga Ab |
6 |
| #142 |
Craig W. Gleason |
ExxonMobil |
6 |
| #142 |
George C. L'Heureux |
ExxonMobil |
6 |
| #142 |
Gina R. Kritchevsky |
Allied Consulting |
6 |
| #142 |
Yogita Krishnamachari |
Array Biopharma |
6 |
| #142 |
Justin C. Lewis |
Wal-Mart Stores |
6 |
| #142 |
Aaron J. Moment |
Merck |
6 |
| #158 |
Marshall R. Angeles |
Merck |
5 |
| #158 |
Thierry Olivier Fischmann |
Merck |
5 |
| #158 |
Kelsey Norwood |
L'Oreal |
5 |
| #158 |
Mikhail Gotliboym |
Merck |
5 |
| #158 |
Eugene Louis Benfatti |
— |
5 |
| #158 |
Anil Chaturvedi |
AT&T |
5 |
| #158 |
Huifeng Niu |
Roche Glycart Ag |
5 |
| #158 |
Joseph J. Marazzo |
The Brooklyn Union Gas |
5 |
| #158 |
Thomas M. Bennett |
— |
5 |
| #158 |
Marc Estriplet |
Colgate-Palmolive |
5 |
| #158 |
John G. Martin |
Applied Materials |
5 |
| #158 |
James E. Hardy |
ExxonMobil |
5 |
| #158 |
Alan A. Schetelich |
ExxonMobil |
5 |
| #158 |
John F. Abreu |
Source |
5 |
| #158 |
Graham Smith |
Microsoft |
5 |
| #173 |
Sergey Anatolyevich Babkin |
Sybase |
4 |
| #173 |
Jonathan Joshua |
Bgc Partners |
4 |
| #173 |
Thomas W. Doebber |
Merck |
4 |
| #173 |
Thomas M. Putvinski |
AT&T |
4 |
| #173 |
Cammy R. Abernathy |
AT&T |
4 |
| #173 |
Christine Mary Gerveshi |
AT&T |
4 |
| #173 |
Y. M. Faruq Marikar |
Hoechst Celanese |
4 |
| #173 |
Menzy Scott |
— |
4 |
| #173 |
Michael T. Melchior |
ExxonMobil |
4 |
| #173 |
Chung K. Shih |
ExxonMobil |
4 |
| #173 |
Byung Gyu PARK |
AT&T |
4 |
| #173 |
Tracey Mochnal |
Bank of America |
4 |
| #173 |
W. Michael Seganish |
Merck |
4 |
| #173 |
Michael Hohn |
Yale University |
4 |
| #173 |
Soo-Chul Han |
Lsi |
4 |
| #173 |
Puneet Girdhar |
Amazon |
4 |
| #173 |
Christopher Michael Tan |
Merck |
4 |
| #173 |
Amit Sachdev |
Colgate-Palmolive |
4 |
| #173 |
Rebecca Leibowitz |
Johnson & Johnson |
4 |
| #173 |
Lun Ye |
Lsi |
4 |
| #173 |
Jeffrey T. Wright |
Graphic Packaging International |
4 |
| #173 |
Chuanxing Qu |
Pharmacopeia |
4 |
| #173 |
Brian E. Doyle |
Bank of America |
4 |
| #173 |
Qingmei Hong |
Merck |
4 |
| #173 |
David J. Smith |
Bell Communications Research |
4 |
| #173 |
Andrew James Nation |
Bristol-Myers Squibb |
4 |
| #173 |
Amy R. Bittner |
Merck |
4 |
| #200 |
V. Richard Guilmette |
Dentsply Research And Development |
3 |